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Abstract
There are apparent problems and fragmentation in the health care delivery system across all
specialties, specifically oncology. Oncology is an area within the health care system that has an
exponential growth of patients. The incidences of newly diagnosed cancer patients are increasing
annually, and the improvements in cancer treatments allow patients to live beyond cancer,
resulting in an increased volume of survivors annually as well. These increases place an
incredible demand on our health care system, including, but not limited to, primary care
physicians and specialists such as medical oncologists. With these increases, there is still an
evident gap within oncology survivorship care as one transitions from the end of treatment to
survivorship care. This study revealed that more than 50% of nurses surveyed believed
survivorship care plans (SCPs) were beneficial to cancer survivors. It was also revealed that
more than 50% of cancer centers or programs represented in this study utilized SCPs in some
fashion. Based on this study, survivorship care seems to be recognized as important, but barriers
prevent consistency in these patients receiving an SCP and smoothly transitioning to
survivorship care. To date, programs and models have been initiated but do not provide enough
evidence on the health outcomes of cancer survivors. Also, there is still poor utilization related to
the development and implementation of SCPs. This issue raises concern and leads to this project,
an evaluation of cancer nurse providers’ implementation of the 2018 Commission on Cancer
survivorship care plan requirement. This requirement entails 50% of eligible survivors receive an
SCP.
Keywords: cancer patients, cancer survivor, quality of life, survivorship care,
survivorship clinic, survivorship care plan
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Chapter 1: Introduction
A cancer diagnosis is frightening and may be challenging to comprehend. Any person
receiving this diagnosis may struggle with a rush of emotions and trouble focusing, which tend to
come along with a cancer diagnosis (Meierhofer, 2020). Consequently, it may also be difficult
for patients to understand the type of cancer, stage, prognosis, and available treatment options.
Also, it may be challenging for one to think beyond the diagnosis and treatment phases of the
cancer journey or having a plan for survivorship. Thus, it would be of no surprise if the
conversation of a survivorship care plan (SCP) or the survivorship phase did not come up at the
time of diagnosis or during active treatment. This discussion may not be approached until the
patient is at the point of transitioning into the long-term survivorship care phase with their
primary care physician or nurse provider. While survivors need to be more proactive in their
care, health care providers can help by providing a survivorship care plan as one transitions into
the survivorship phase.
The survivorship phase of the cancer journey is the phase that is before the end-of-life
phase; thus, it is after the diagnosis and active treatment phases. In an ideal situation, educating
patients at the beginning of one’s cancer journey about each phase may help patients become
familiar with the entire cancer journey, including the survivorship phase and what to expect. At
the survivorship phase, the patient has completed active treatment and is considered
posttreatment. Oncologists will release the cancer survivor back to the community for their
primary care physician or nurse provider to carry out long-term surveillance. Survivorship care
as a whole is still developing; however, patients who are transitioning into this phase may have
specific and challenging needs to meet. Moreover, the transition from one’s oncologist’s care to
the primary care physician’s care may not be as smooth as it could be (Debono, 2010).
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The need for transitioning to the cancer survivorship phase is that the incidence of cancer
cases continues to rise as per the Surveillance, Epidemiology, and End Results (SEER) program.
SEER estimated a higher number of new cancer cases per year within the United States: For
example, there are approximately 270,000 breast cases, 175,000 prostate cases, and 146,000
colon cases, totaling greater than 590,000 cases of cancer (National Cancer Institute, 2019). This
total reflects only the top three cancer locations within the body. Additionally, the National
Cancer Institute (2019) estimated there were 16.9 million cancer survivors, male and female, in
the United States. The survivorship numbers are projected to increase to more than 20 million by
2026 (National Cancer Institute, 2019). Also, the increased needs and demands specific to cancer
survivors will increase (Nekhlyudov et al., 2017). This volume of cancer survivors demonstrates
a need for more focus on the SCP and survivorship phase. Conceivably, the SCP enables
sufficient communication, coordination of care, smooth transition into the survivorship phase,
and ongoing high-quality care, thus resulting in possibly improved quality of life and health
outcomes.
Statement of the Problem
The number of cancer survivors is significantly overwhelming. Cancer survivors account
for almost 17 million of the overall cancer population, including both genders (National Cancer
Institute, 2019). These sheer numbers and volumes of survivors are significant and growing.
Having these volumes intensifies the gaps and barriers within the health care system, specifically
with the survivorship phase of the cancer journey. Several critical gaps exist with cancer
survivors who have reached the end of active cancer treatment and surveillance and are released
by their oncologist, known as the long-term survivorship phase (completed active treatments and
surveillance with their oncologists). While there may be improvements in survivors’ care with
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the different survivorship care models and survivorship care plans (SCPs), this phase of the
cancer journey currently does not address all the needs of this population (Gast et al., 2017).
Also, it has not demonstrated quality-of-life improvements or health outcomes (Gast et al.,
2017). It is important to recognize that some small studies may have shown levels of satisfaction
with cancer survivors in the survivorship phase, which includes being aware of which doctor is
in charge, increased confidence, adhering to surveillance recommendations, exercise, and
reporting their health outcomes (Mayer et al., 2016). Still, cancer survivor satisfaction is a
separate issue from quality of life and health outcomes issues and SCP implementation (Nyarko
et al., 2015).
The cancer survivorship phase is an evolving science and practice that supports cancer
patients who have completed active treatments and surveillance with their oncologists. Currently,
survivors may transition back to their primary care physicians (PCPs) within the community for
long-term survivorship care if their oncologist releases them. Concerns arise with the
survivorship care plan concept and with the actual transitioning to the survivorship care phase.
Some of these concerns include the following: (a) inconsistent SCP development and
implementation, (b) unmet needs, (c) communication and coordination of care, (d) the primary
focus of the oncologists and PCPs once a cancer patient reaches the survivorship phase, and (e)
recurrence and unknown health outcomes associated (Lisy et al., 2019).
Background
Survivorship Care Plans
Survivorship care plans (SCPs) are a tool that tells the story of the cancer patient’s
journey in a high-level summary manner (Cancer.net, 2020). There are different organizations
other than Cancer.net that have web-based SCP templates. Implications of this tool are to help
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educate the cancer survivor, and their primary care physician or nurse provider on the survivor’s
cancer, treatment(s) underwent, and long-term and late-term side effects of the treatment(s).
Also, as an overview of the cancer survivor’s history, the SCP is utilized as a communication
tool for oncologists and survivors’ PCPs or nurse providers for transitioning the survivor. The
use of this tool may help the providers to smoothly move and coordinate the survivor out of the
oncology setting and into the community setting where long-term survivorship care will
continue. In simpler terms, the oncologist no longer needs to see the patient, and the PCP or
nurse provider will take over the patient’s care. In doing so, a completed and implemented SCP
may prove to be of great importance to help facilitate communication, transition, and
coordination of care for the cancer survivor and may have a positive impact on the quality of life.
Survivorship Care Phase and the Survivorship Care Plan
The survivorship care phase (acute and extended), not to be confused with the
survivorship care plan, is the point a cancer survivor starts shifting from the diagnosis to acute
survivorship care, also known as the active treatment phase, and then onto the extended (also
known as long-term) survivorship care, which is post–active treatment and is living beyond
cancer (Goetz & Klemp, 2018). This phase is the point of celebration in that the cancer survivor
has successfully reached it and no longer needs to see their oncologist unless there is a
recurrence, new cancer diagnosis, or other reason. However, the cancer survivor still requires
long-term survivorship care with a provider outside the oncology setting due to cancer and
treatment(s) they have undergone. All cancer patients will go through the cancer journey, which
comprises several phases. These phases include the diagnosis phase, treatment phase, follow-up
phase, and end-of-life phase. Follow-up evaluations vary based on the individual, cancer site or
location, the complexity and stage of cancer, and the necessary treatment or treatments (e.g.,
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surgeries, chemotherapy, immunotherapy, maintenance therapy, etc.). Subsequently, the cancer
patient will eventually reach and begin the long-term survivorship phase of care, barring no
complications or death.
The purpose of the SCP tool and the survivorship care phase is to support the prevention
and surveillance of recurrence, new cancers, side effects, and long-term and late effects; the
intervention for the consequences of cancer and its treatment; and the communication and
coordination between specialists (oncologists) and primary care providers (PCPs). Sadly, for
cancer survivors, the definition of the survivorship care phase is not clear. Moreover, the
Institute of Medicine’s report with survivorship care recommendations was issued almost 15
years ago, and yet it seems as if there is no consistent practice in place for this patient population.
Also, there are no best clinical practice suggestions for the survivorship care phase, SCPs are still
inconsistently developed and implemented, and there is no clear demonstrated understanding of
outcomes (Gast et al., 2017).
The Institute of Medicine’s report of 2005 provided multiple recommendations for
patients transitioning from active cancer treatment to life after cancer treatment, the survivorship
care phase (IOM, 2013). These recommendations included the development and dissemination of
SCPs to help patients understand their prior treatment(s) and survivorship care—and, thus, life
after cancer and what to expect. It is presumed that oncologists will develop an SCP and share a
copy with the patients and the patients’ PCPs in efforts to promote communication and highquality long-term survivorship care. While the IOM’s recommendations focus on life after
cancer, there is no emphasis on best practices or how to incorporate it into practice. Awareness
of the importance of the survivorship care phase with an SCP, once released from the oncologist,
is equally as important as diagnosis and active treatment and surveillance with the oncologist. In
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reality, it appears that not all survivors have SCPs developed, or the sharing of SCPs with
patients or their PCP is not consistently happening. It seems that developing SCPs is a timeconsuming process and requires dedicated resources that may not be financially feasible in an
oncology practice or hospital setting (Mayer et al., 2014).
However, ideally, all cancer survivors entering the survivorship care phase of their cancer
journey, including their PCP or nurse provider, would have an SCP developed, shared, and
implemented. At that point, the oncologist and PCP or nurse provider would communicate and
coordinate care, and the PCP or nurse provider would also review the SCP with the cancer
survivor and begin a partnering relationship for long-term survivorship care. Then, the SCP is
considered implemented by the PCP or nurse provider. The PCP or nurse provider will
communicate as appropriate with the cancer survivor’s oncologist during survivorship care. The
implemented SCP tool should orient and aid PCPs or nurse providers in observing survivors’
history and health, such as earlier diagnosis of possible recurrences and new cancers,
surveillance of cancer spread and second cancers, and long-term and late side effects; proposing
interventions and treatment options; managing care; and ensuring appropriate health needs are
met (Chaput, 2018). Additionally, the SCP document may further help with engagement and
partnerships with both providers and the cancer survivor.
Possible Idea for Advancement in Survivorship Care Phase
In an ideal world, a possible advancement for survivorship care includes a nurse-led
dedicated clinic and the consistent development and implementation of SCPs for cancer
survivors. However, removing the gaps and barriers related to the lack of communication and
coordination between both primary and specialty care physicians should be addressed. Also,
these providers must proactively overcome their differences in role perspectives, responsibilities,
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lack of communication, and any other barriers that may prohibit delivering high-quality care and
a smooth transition. After the gaps and barriers are eliminated, the movement toward consistent
SCP development and implementation could begin and the efforts for high-quality survivorship
care might commence. Subsequently, the focus shifts back to the patient—hence, patientcenteredness. It seems there is a drop in any structure and high-quality care as one reaches the
survivorship care phase. A cancer survivor becomes accustomed to high touch points and highquality care while moving through the diagnosis and active treatment phases. Then, upon
entering the survivorship phase, many cancer survivors are left trying to sort and figure out their
survivorship care and requirements. Also, it should be recognized that the SCP is just a tool to be
used to assist providers and survivors with survivorship care. Even if the SCP is developed, it
needs to be shared, as the SCP document does not directly deliver the care or actively improve
health outcomes.
Consistently completed and implemented SCPs could serve as a vehicle toward highquality care and possibly improved health outcomes for cancer survivors. Even though among
breast cancer survivors, it has been noted that some patients may receive SCPs and are more
educated on their doctors’ expertise and specific medical responsibilities, still no health
outcomes have been collected or evaluated. This also does not mean these cancer survivors
received high-quality care. Plus, to date, it is well known that many patients and PCPs are not in
receipt of an SCP (Donohue et al., 2017). In many cases, the PCP may not even be alerted that
their oncologist is releasing the cancer survivor unless they learn it from the cancer survivor.
Therefore, it is clear that a lack of communication and coordination of care among the
oncologists and PCPs exists. A shift back to patient-centeredness is essential and could be done
with the consistent development and implementation of the SCP document. In turn, this might
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help support gaining clinical evidence of the quality of life and health outcomes associated with
an SCP implemented during the survivorship phase as well as helping cancer survivors be better
patients. Also, in doing so, it might lead to a better understanding of the impact of the SCP on
breast cancer survivors and future research initiatives.
Purpose of the Study
The purpose of this quantitative nonexperimental project is to explore the cancer nurse
providers’ implementation of an SCP on cancer survivors who are post–active treatment and
within the survivorship phase. To understand the nurse provider’s behaviors, a 20-item
questionnaire was utilized. Learning these outcomes will help drive the direction of survivorship
care toward smoother transition, better communication, coordination of high-quality care, and
potentially meeting the majority of needs of the cancer survivors. Cancer survivors have
outnumbered the newly diagnosed cases and continue to grow due to more patients surviving
their cancer and treatment and technology improvements. Understanding the nurse providers’
utilization of an SCP on cancer survivors is essential for recommendations for future
improvements. Currently, the effects of an SCP on the cancer survivor in the survivorship phase
are not clearly understood, so moving toward consistency is important. Gaining insights into
SCP utilization will help toward advancements and higher quality in this care.
The survivorship care phase, with full utilization of an SCP, should support
communication and transition among providers, surveillance for prevention, detection of new
and recurrent cancers, long-term and late effects of treatments, and continuous management of
care. The assumption of consistently developed and implemented SCPs will elevate the
survivorship phase and may have a domino effect on the survivor. Thus, survivors would have a
better understanding of their cancer, treatments experienced, and what to expect with ongoing
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surveillance; potentially less stress and anxiety; and a smoother transition into the survivorship
phase. Presently, this is not always the norm in the survivorship care phase practice. Moreover,
cancer survivors are used to having a high level of touch points before entering the long-term
survivorship care phase. The survivorship care phase should be no different. This SCP and
survivorship care phase is an area within health care that provides plenty of opportunities for
exploring it further.
Significance of the Problem
Oncologists’ patient volumes are growing considerably each year, which includes new
patients, active patients, and posttreatment patients who have reached the point of being released
back to the community. The latter are known as cancer survivors who are entering into the
survivorship care phase. With this group of cancer survivors who are ready to be released by
their oncologists, there is an exponential increase in this population annually. This increase
creates a burden on oncologists and primary care physicians and their ability to sustain delivering
high-quality care to such a growing population. Coordination and transitioning of cancer
survivors from the oncology setting and into the primary care setting is a necessary shift. A
clinical tool known as the survivorship care plan helps with this transition. However, there are
barriers related to the development and implementation (also known as full utilization) of SCPs
and the survivorship care models. These identified barriers include the following (Gast et al.,
2017):
1. Oncologists do not have confidence in the PCPs to manage the ongoing follow-up of
survivors who have reached the survivorship phase.
2. Oncologists are not comfortable with the skills and knowledge base of PCPs in
survivorship care.

10
3. Survivorship care lacks coordination of care, communication, and responsibilities
among the oncologists and PCPs involved
4. The different providers have different focuses. Oncologists concentrate their practice
on receiving and managing new cancer cases, managing patients who are in active
treatment, and standard follow-up practices for post–active treatments. PCPs’ efforts
are focused on conducting screening activities for diseases and health-related issues,
education, and health promotion for new and current patients.
5. Developing SCPs are time-consuming and require dedicated resources.
Also, a bill recently passed into law allows more patients access to health insurance, thus
increasing the volume of patients for both providers. This legislation is known as the
Accountable Care Act (ACA), which has enabled more access to health care for preexisting
conditions, the ability to purchase coverage outside the workplace, the ability for children up to
26 years of age to continue on parents’ insurance, and elimination of lifetime expenditure limits
(Nekhlyudov et al., 2017). This further increases the volume of patients and the clinical burden
for oncologists and primary care providers. Other barriers include the demand for high-quality
care, the complexity of care, required provider skill sets, and new technologies. These barriers
have an impact on the current models of survivorship care, contributing to the unmet needs of
this patient population.
Nature of the DNP Project
The nature of this DNP project is to evaluate the cancer nurse providers’ implementation
of the 2018 Commission on Cancer’s SCP requirement within survivorship. Anyone familiar
with the survivorship care phase of health care may not be surprised that there are gaps in this
phase of the cancer journey. Some of the gaps that have been noted involve the lack of
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communication and continuity of high-quality care. Moreover, the lack of consistently
developing and implemented survivorship care plans for cancer survivors makes it hard to
measure the quality of life and health outcomes (Gast et al., 2017). Regardless of the IOM,
extensive recommendations for survivorship care, survivorship care models, and implemented
survivorship care plans, this patient population’s needs are not being met and there is little
evidence of the effects on quality of life and health outcomes (Gast et al., 2017). Understanding
the cancer nurse providers’ behaviors with SCP utilization, which includes the development and
implementation of SCPs for patients or their primary care providers, will help to show how to
begin to fill these gaps.
In 2016, the Commission on Cancer (COC) issued a requirement to be met by 2018 and
beyond, which entails that 50% of eligible cancer survivors would receive a survivorship care
plan (COC, 2016). Eligible cancer survivors are those patients who are in stage I, II, or III.
Patients who are stage 0 or IV are excluded from the COC’s requirement (COC, 2016). Stage 0
may not require treatment, only surveillance, whereas stage IV is typically terminal.
The study’s limitations were related to enrollment being limited to cancer nurse providers
who were members of an oncology nurse society. No other health care providers were eligible to
participate in this project. Despite all the good intentions and governing requirements, it was
assumed that many survivors might not have been aware of an SCP and/or had never received an
SCP from their oncologist or cancer center. Additionally, this project was a self-reported
nonrandomized control trial with no control group for comparison.
Research Questions
The PICOT question guiding this project was an evaluation of cancer nurse providers’
implementation of the 2018 Commission on Cancer survivorship care plan requirement.
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P—cancer nurse providers’ implementation of the Commission on Cancer’s requirement
for the implementation of a cancer survivorship care plan for 50% of eligible patients by
2018 and beyond
I—have cancer nurse providers implement this requirement and identify what are the
benefits and barriers to implementation
C—a comparison of cancer center types, personnel disciplines, cancer locations,
survivorship care plan implementation, and barriers
O—to identify processes and practices for implementation and sustainability of a cancer
survivorship plan
T—one month
As mentioned, the study population came from an oncology nurse association that
included cancer health care providers who are nurses at various health care centers throughout
the United States. This project was not a randomized clinical trial, and there was no comparison
group for this study. The 6-month time frame was selected to allow for the recruitment of this
study’s population and responses.
Theoretical Framework
Lewin’s theoretical framework was an essential component of this DNP project to bring
awareness to start moving from inconsistently to consistently developing and implementing the
SCP for cancer survivors. Lewin’s framework consists of a change in current practice and moves
to a new practice—for example, in this case, consistently utilizing SCPs for cancer survivors in
efforts for coordinating their care and supporting a smooth transition into survivorship care post–
active treatment. In doing so, this practice change may improve cancer survivors’ health
outcomes, unmet needs, quality of life, and psychosocial aspects.
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Operational Definitions
Cancer patient. A cancer patient is an individual (patient) who has been diagnosed with
cancer and requires medical treatment from an oncologist(s).
Cancer survivor. A cancer survivor is an individual (patient) diagnosed with cancer who
has undergone medical treatment from an oncologist(s) and is in or has entered into the
survivorship phase.
Commission on Cancer. The CoC is an organization under the American Society of
Clinical Oncology that establishes requirements to help improve patients’ outcomes.
Quality of life. Quality of life measures one’s ability to function at or close to their
baseline status before the illness, health crisis, or event that may have changed their baseline.
Survivorship care. This is the care delivered in the survivorship care phase of the cancer
journey where high-quality care and surveillance of an individual who has completed active
treatment require follow-up with their oncologist.
Survivorship care phase. The survivorship care phase is the phase of the cancer journey
where an individual has completed their active treatments and required follow-up with their
oncologists. This phase usually beings at the 5-year mark from a cancer diagnosis and
throughout the rest of the survivor’s life.
Survivorship care plan. A survivorship care plan is a document that includes in detail an
individual’s medical history and includes details about the treatments (cancer treatments) and
any potential medical plans and surveillance requirements.
Scope of Project
The scope for this DNP project entailed a survey of cancer nurses across the United
States. The project was done by collaborating with the Oncology Nursing Society (ONS). At the
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time of study, this organization had over 35,000 members. The inclusion criteria for this project
included members of ONS and registered nurses only. The exclusion criteria were anyone who
was not a registered nurse within the ONS. To ensure inclusion criteria were met, the ONS
filtered their membership for registered nurses only. Once their members were filtered, then the
ONS emailed the survey link and information regarding this study to each member. An existing
nonvalidated survey tool was utilized, which entailed 20-items around survivorship care plans.
The author of this survey provided their approval to use for this DNP project. The study survey
was created in SurveyMonkey and this survey was open for a month to ensure all participants
had time to complete the survey. Also, within this timeframe, ONS sent email reminders to all
the filtered members. Once the survey was closed, after a month, the data were exported from
SurveyMonkey and imported into a statistical program for data analysis. Each survey item was
analyzed using descriptive statistics.
Chapter Summary
The aim of this study was to understand cancer nurses’ implementation of survivorship
care plans based on the Commission on Cancer 2018 recommendations. Since the
recommendation of the IOM, the utilization of SCPs has been inconsistent. Also, no health
outcomes have been determined with the utilization of SCPs. Therefore, the true value of the
SCP is not well understood. However, nurses are critical in the smooth transition and care
coordination of patients as they move throughout the health care system. SCPs provide an
opportunity for nurses to support patients who are entering the survivorship care phase of their
cancer journey and potentially impact their outcomes positively.
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Chapter 2: Literature Review
A review of the literature was completed to understand the current state of the science
related to cancer survivors who have entered the survivorship care phase of their cancer journey
and the development, implementation, and delivery to patients or their PCP or nurse provider of
SCPs. SCPs are recommended for patients who have completed active cancer treatments and are
released by their oncologists to the community. The SCP document is a tool to facilitate the
communication and coordination of care between providers.
The leading search terms were derived from the PICOT question and included cancer
survivorship care, survivorship care, breast cancer survivorship phase, cancer survivorship care
plan, breast survivorship phase, survivorship outcomes, quality of life of cancer survivors,
clinical guidelines for cancer survivorship care, primary care physicians involved in
survivorship care, and implementation of cancer survivorship care plans. The search engines
utilized included the National Center for Biotechnology Information (NCBI)–PubMed,
ScienceDirect, and the Abilene Christian University (ACU) Library database powered by
EBSCO (includes CINHAL, OVID). Articles from January 1, 2012, to current, peer-reviewed
and in the English language, were reviewed and considered. The number of academic articles in
AC-EBSCO resulted in 537; the number of findings in NCBI-PubMed resulted in 1,521, and the
number of findings in ScienceDirect resulted in 38. Articles that were excluded included articles
that did not pertain to cancer or cancer survivorship care.
Cancer Survivors
Cancer patients are living beyond their cancer diagnosis and associated treatments (IOM,
2013). The advancements in oncology therapies continue to improve, and so do survival rates.
Therefore, the number of cancer survivors continues to increase every year, as well as the
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number of new cancer cases. The journey of a cancer patient begins at diagnosis and continues
until the end of life. The continuum of care includes the diagnosis phase, active treatment phase,
follow-up phase, and survivorship care phase through the end of life (IOM, 2013). A medical
oncologist directs cancer patients’ care and treatments within a specialty oncology clinic. Once a
cancer patient completes their active treatments and required follow-ups with their oncologist,
the oncologist releases these patients back to their PCP or nurse provider. This time frame is
usually 3–5 years of post–active treatment and follow-up. In efforts to provide adequate care to
cancer patients who are entering into the survivorship phase of their journey, the IOM issued a
report in 2005, which indicated that patients should receive an SCP based on their cancer history
and treatment. The SCP tool was revealed to support and possibly improve the survivors’ care as
they transitioned from their oncologist out of the oncology setting. The concern at that time and
currently is that cancer survivors were and are not receiving comprehensive, coordinated, highquality, long-term follow-up care during survivorship.
Some oncology clinics or hospitals have developed SCPs and programs; however, the
actual development and implementation of SCPs and programs are either inconsistent, minimally
utilized, or nonexistent across health care systems. It has been mentioned in the literature that
some institutions went as far as to hire external staff to implement the minimally required
percentage of SCPs for cancer survivors to meet national obligations (Birken, 2018). Also
mentioned in the literature, some institutions have implemented a small percentage of SCPs with
their cancer survivors (Birken, 2018). However, evidence of health outcomes has not been
collected or evaluated. Additionally, the existing gaps, barriers, and a complex health care
system contribute to the cancer survivor’s inability to receive high-quality, long-term
survivorship care.
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Delivering High-Quality Cancer Care
A study committee was formed to understand the evidence behind the IOM’s
recommendations on survivorship care plans and models. This committee reviewed the evidence
behind the IOM’s initial 1999 report of the 10 recommendations to improve cancer care (IOM,
2013). Their recommendations focused on cancer survivors and their needs. These needs
included (a) raising awareness; (b) survivors receiving an SCP; (c) evidence-based guidelines
and tools to identify and manage late effects; (d) developing quality measures and quality
assurance programs; (e) testing models of survivorship care in diverse communities; (f) SCP
implementation, evaluation, and refinement; (g) educational opportunities to health care
providers to address survivors’ needs; (h) eliminating discrimination against cancer patients in
the workplace; (i) ensuring survivors have access to adequate and affordable care; and (j)
governmental agencies supporting survivorship research (IOM, 2013).
The survivorship definition remains unclear. IOM (2013) defined survivorship care as a
phase of care in which the care delivered for cancer survivors involves four components. These
components include prevention and detection of new cancers and recurrent cancers; surveillance
for cancer spread, recurrence, or second cancers; intervention for consequences of cancer and its
treatment; and coordination between specialists and primary care providers to ensure that all of
the survivor’s health needs are met (IOM, 2013).
The IOM report also revealed that as the U.S. population increases over the next 20 years,
so will the total cancer incidences (IOM, 2013). Equally, the incidences of cancer survivors will
continue to grow. Interestingly, out of a U.S. population of more than 300 million people,
approximately 17 million people are cancer survivors (American Cancer Society, 2019).
Projections estimate that the total number of cancer survivors will reach 22 million, both male
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and female, by 2030 (American Cancer Society, 2019). Of note, the most prevalent tumor sites
continue to include breast, prostate, lung, and colorectal cancer, which are the bulk of cancer
survivors.
The cancer journey is often complicated and complex. Cancer care encompasses the
initial diagnosis phase, active treatment, and posttreatment surveillance with an oncologist,
transitioning to the survivorship phase, which lasts until the end of one’s life. Due to the total
patient volume (cancer diagnosis and survivors), the disease and its treatment, a shrinking
workforce, access, disparities, and rising costs, there is a crisis in cancer care delivery across the
board. Many patients do not receive an adequate explanation of their treatment goals and cancer
journey (Smith & Ferrell, 2014). When a phase of treatment concludes, cancer survivors
frequently do not know what treatments they have received or the consequences of their
treatments for their future health, or their follow-up requirements (IOM, 2013).
Primary Care Physician-Delivered Survivorship Care
Nyarko et al. (2015) evaluated cancer survivors’ perspectives on survivorship care
delivered by primary care physicians (PCPs). These researchers found that the cancer survivors
were most interested in general care, psychosocial support, and holistic care almost equally.
Interestingly, survivors were less likely to perceive their PCP as knowledgeable about cancer
follow-up, late or long-term effects of cancer therapy, or diagnosis and treatment of symptoms
related to disease or cancer therapy also equally. While a large percentage of survivors reported
satisfaction with their PCP care overall, a small percentage felt that their PCPs and oncologist’s
communication and coordination were lacking. This study also brought an understanding around
the fact that if patients visited their PCP more frequently (i.e., two or more times a year), they
held a higher trust level and satisfaction in their PCP’s ability to provide survivorship care
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(Nyarko et al., 2015). Still, patients felt that the PCPs did not have the knowledge and expertise
to identify new cancers or cancer treatment-related effects (Nyarko et al., 2015). Yet, these are
the core of survivorship care, as well as communication between primary and specialty care.
Primary Care Provider and Cancer Specialist Relationships
Dossett et al. (2017) shared the relationship and communication between PCPs and
cancer specialists lacks the frequency, timing, and content desired by PCPs who are trying to
provide survivorship care. PCPs and cancer specialists both expressed skepticism regarding the
other’s ability to play their role. Cancer specialists felt that PCPs lack familiarity with cancer
treatments and surveillance, and PCPs noted that cancer specialists neglect psychosocial care,
which they believe PCPs are better positioned and equipped to provide (Dossett et al., 2017).
While cancer specialists want to hold onto the cancer survivor throughout the long-term
survivorship care phase, PCPs are willing to participate in the continuum of care even before
transitioning to the long-term survivorship care phase for better coordination and continuity of
survivorship care.
McDonough (2019) shared the experiences and preferences of primary care physicians
around opportunities to improve care for cancer survivors. These researchers found that while
most PCPs within an integrated health care system are engaged in survivorship care, many PCPs
feel inexperienced in screening for late complications of therapy and recurrence. Among these
PCPs, a significant number of these physicians considered themselves not properly equipped to
screen for new complications and recurrences. Interestingly, the researchers found that most
PCPs were uncertain of the delegation of responsibilities between providers, and they also had a
lack of training in oncology care. On a positive note, these primary care physicians were very
interested in the shared caring of cancer survivors. These physicians exhibited a willingness to
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optimize communication and care coordination between providers. They also appreciated
survivorship care plans with active tracking of the needs, problems lists, and follow-up
requirements over receiving a traditional summary document that lacks details of the cancer
survivor’s cancer history (McDonough, 2019).
Survivorship Care Plans Toward High-Quality Survivorship Care
Truant et al. (2019) identified that there is no clear description of survivorship. They
found extensive variability in the definition. Some of the definitions they noted in their research
include the following (Truant et al., 2019):
•

the beginning of diagnosis and continuing for the remainder of one’s life;

•

the start after primary treatment and lasting until recurrence or end of life; and

•

the transition between active treatment and primary care.

The researchers also identified that health care systems were more focused on the matters
of the population and system level than at the individual level (Truant et al., 2019). Additionally,
these researchers shared that patients felt abandoned to the primary care system relegated to
oversight by practitioners who were viewed as unskilled in matters of cancer (Truant et al.,
2019). Many patients felt access to survivorship care was prioritized based on the presence or
absence of disease, as well as the severity of the disease. Many felt shut out of a system that only
focused on pathology. Also, patients felt that the system was disinterested in late- and long-term
effects of treatment and the lingering psychological effects of the life-altering experiences they
had experienced with cancer care and treatment (Truant et al., 2019).
The researchers’ interviews were dominated by accounts of how their expectations for
cancer survivorship care failed to match their anticipated hope for reality. Most survivors had
expected to receive patient-centered, individualized, holistic care within an ongoing and
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reciprocal relationship with their health care provider. The cancer survivors also had a perception
of self-care activities. However, the reality of the situation was based on the differences in care
received. The differences in care received included survivors who lived in rural versus remote
areas and had concurrent chronic conditions; were younger versus very old adults; had
noncurable, rare, or complex cancers; spoke English versus other languages; or represented other
identifiable equity groups. These survivors had significantly lower expectations that their needs
would be met relative to the average patient. Those who had other tumor sites than breast cancer
perceived themselves to be at a disadvantage. Stakeholders interviewed exhibited institutional
arrogances concerning the challenge of increasing numbers of cancer survivors and whose
responsibility it is to support them (Truant et al., 2019). There needs to be consistency in the
utilization of SCPs in survivorship care.
Implementation of Survivorship Care Plans and Outcomes
Brennan et al. (2014) looked at the development and implementation of SCP involving
cancer survivors across many cancer sites who were in the survivorship phase of their care.
These researchers found no significant effects of SCP on survivor distress, satisfaction with care,
cancer care coordination, or oncological outcomes. Brennan et al. (2014) did note that breast
cancer survivors with implemented SCPs understood which health care provider was responsible
for which part of their care. They also found high levels of survivor satisfaction with their SCP.
However, they found that the health care providers’ perspectives on the development and
implementation of SCP are a significant barrier in and of itself. For example, they reported that it
took 1 to 4 hours of a health care provider’s time to develop an SCP (Brennan et al., 2014);
therefore, these health care providers question the feasibility of these SCPs. It is tricky to
question the use when there is no evidence to report positive or negative outcomes with SCPs.
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De Rooij et al. (2016) wanted to look at factors that influence the implementation of
SCPs and the patients’ and providers’ issues that influence SCP receipt. In doing their study,
they found that SCPs are not generated for all cancer survivors and that not all patients who have
SCPs developed for them receive their SCP. Therefore, further research efforts need to focus on
SCPs, whether all patients need an SCP, the consistent implementation of an SCP, and an SCP
utilization and associated impact (de Rooij et al., 2016).
Birken et al. (2019) reviewed SCP implementation across 10 cancer programs. These
researchers found that these 10 programs only developed SCPs for more than half of their
eligible cancer survivors; only two programs delivered SCPs to any survivors, and the other eight
delivered the SCPs to a quarter or more of their survivors’ PCPs. They classified the programs at
these centers as either high, moderate, or low performers. The moderate performers successfully
implemented SCPs using strategies such as proactively responding to SCP requirements,
leveraging SCP requirements to improve survivorship care, and restricting SCP implementation
to a subset of employees, primarily advanced practice providers for whom the task is appropriate
and a component of their defined role. Their study results also revealed the ongoing persistent
challenges of SCP implementation.
Interestingly, Birken et al. (2019) suggested that implementation of SCP was done only
for accreditation purposes and that these survivorship program centers do not deliver the SCPs to
survivors because of the substantial additional amount of time and human resources commitment
required. Therefore, if survivors and PCPs are not receiving these SCPs, patients are unlikely to
achieve the desired health outcomes. Moderate performers tasked some employees with SCP
implementation, but it is divorced from fundamental improvements in survivorship care. Also,
there was evidence to suggest that the moderate performers hired external staff to complete and
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deliver these SCPs to survivors and PCPs—hence, breaking the goal of coordination of care and
communication between health care providers.
Commission on Cancer Requirement
The Commission on Cancer (COC) is a group of professional organizations that set
standards and are focused on improved outcomes for cancer patients. This group falls under the
American College of Surgeons. Since 2015, the COC set requirements for the percentage of
survivors who should receive an SCP (ACOS, 2020). The COC allowed for a slow rollout of this
requirement: In 2015, greater than or equal to 10% of eligible patients were to receive an SCP
and then that figure would increase annually. The gradual increase in 2016 was greater than or
equal to 25%; in 2017, greater than or equal to 50%; and in 2018, greater than or equal to 75%
(COC, 2016). As of January 1, 2019, the COC requirement included that all eligible patients
should receive an SCP (ACOS, 2020).
The COC also recommended that the primary oncology provider be the one tasked to
develop and implement an SCP. As one could imagine, this is the point of trickiness. Developing
and implementing an SCP is not the primary focus of an oncologist. Also, there is evidence to
support that implementation of an SCP is not ideal or consistent for the primary providers or
clinics or hospitals (Birken, 2018). Birken (2018) stated, “Time, money, and staff are the usual
suspects” (para. 4). In order to understand the health outcomes and the impact of an SCP,
consistent development and implementation of an SCP are necessary (Birken, 2018).
Nurse-Led Clinics May Be an Option to Support Survivorship Care Needs
Nurse-led clinics (NLCs) are an option that has been and continues to be evaluated for
increasing patient access to care. These NLCs have demonstrated positive patient outcomes and
satisfaction. Another advantage of these NLCs is that the location is typically within the
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community where the patients are located. Advance practice registered nurses (APRNs) are wellpositioned to fill the health care provider role for the survivorship phase of care in the cancer
journey. Perhaps, dedicated NLCs could be embedded within primary care physician practices or
nearby settings.
Notably, NLCs have been evaluated within several different therapeutic areas in other
countries and have been considered feasible for follow-up care. Randall et al. (2017) conducted a
systematic review of articles on NLCs and found positive correlations with patient outcomes,
patient satisfaction, patient access, and cost-effectiveness. While their findings on patient
outcomes were related to patients’ self-reporting data versus measurable data, it still
demonstrates that NLCs are potentially viable options (Randall et al., 2017).
Theoretical Framework Discussion
Lewin’s conceptual framework was an essential component of this DNP project to bring
awareness to start moving from inconsistently to consistently developing and implementing the
SCP for cancer survivors. This practice may ultimately improve patient outcomes as well as
allow data to be collected over time for further evidence related to the quality of life and health
outcomes. Lewin’s framework is well known and often used within health care for implementing
a change of practice and is also one of the most adaptable models in nursing, which aligns well
with this point of interest. Lewin’s framework suggests three stages to undergo, which include
the following (Wagner, 2018):
•

Unfreezing (when change is needed)—disequilibrium occurs to disrupt the system,
making it possible to identify the driving forces for the change and the likely
restraining forces against it.
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•

Change or movement (when change is initiated)—involves the process of a change in
thoughts, feelings, and behaviors.

•

Refreezing (when equilibrium is established)—consists of creating the change as a
new habit.

Figure 1 shows Lewin’s change theory with the (a) square representing “unfreezing” the
current state and mindset of survivorship care via inconsistent development and implementation
of survivorship care plans; (b) the raindrops melting into a circle representing the “change or
movement” to consistent development and implemented SCP for each cancer, and (c) the triangle
representing the “refreezing” to the future or new state of survivorship care phase that includes
consistently developed and implemented survivorship care plans for all eligible survivors.
Figure 1
Lewin’s Change Model

(a)

(b)

(c)

Conceptual Framework Discussion
Providing high-quality survivorship care for cancer survivors is as important as any other
phase within the cancer journey. Cancer occurrences or cases and survivors continue to grow
exponentially. The prevalence of cancer survivors exceeds the number of cancer cases. With the
rising population of cancer survivors, it is completely understood why there is so much

26
discussion around providing SCPs and high-quality care to cancer patients who have entered the
survivorship phase of their cancer journey. Further research on health outcomes related to the
survivorship phase and the utilization and implementation of SCPs is necessary. This review of
the literature supports the proposed DNP project that involves adult breast cancer survivors who
are post–active treatment and surveillance and released by their oncologist to a PCP. Once the
oncologist releases their cancer survivor, there should be a high confidence level in PCPs with
this transition to conduct survivorship care based on the SCP as well as to have an impact on the
quality of life of the survivor. These studies discussed the lack of coordinated, high-quality SCP
development and implementation, communication among health care providers, and quality of
life health outcomes. The weaknesses of these studies are that none of the studies have tangible
evidence of the inconsistent development and implementation of SCP and how it impacts health
outcomes.
Chapter Summary
The documented inconsistencies of SCP development and implementation and the lack of
evidence on health outcomes are significant. The smooth transition of survivors from the
oncology setting to the community setting is also important. NLCs provide a viable option for
caring for patients in the survivorship care phase of the cancer journey. NLCs appear to be costeffective and correlated with positive outcomes. Cancer survivors should continue to receive
high-quality care as described by the IOM. The SCP tool could serve to facilitate care
coordination and communication among PCPs or nurse providers and cancer specialists. Full
utilization of the SCP document could help providers get a step closer to delivering high-quality
clinical care during the survivorship care phase of the cancer patients’ journey.
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Lewin’s theoretical framework will provide structure to reset mindsets and recommend
practice change within the survivorship care phase of the cancer journey. Future research is
required in understanding the health outcomes of cancer survivors who have entered the
survivorship phase and any positive correlations with the utilization and implementation of
SCPs.
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Chapter 3: Research Methods
Surviving a cancer diagnosis and associated treatments may have a significant impact on
one’s long-term outcomes and quality of life. Also, transitioning from one’s oncologist back to
one’s primary care physicians or the general community setting may be difficult. Therefore, this
study focused on the cancer nurse providers’ implementation of the 2018 Commission on Cancer
requirement of survivorship care plans (SCPs). The study outcomes are to understand the
percentages of SCPs developed and implemented, barriers, which type of SCP is used, cancer
center type, tumor type, and other items of interest. The importance of SCP use is hoping to
improve coordination of care and survivors’ life after cancer. Furthermore, the Commission on
Cancer has planned to change Standard 3.3 for 2020 to make it optional for providers to give
survivors an SCP. Changing this standard from required to optional will more than likely result
in survivors not getting an SCP at all. Nurses are in the position to continue this practice to
ensure survivors are set up for the best possible outcomes in their long-term follow-up care.
Also, since nurses spend more time with patients than most disciplines, nurses are wellpositioned to activate and engage patients in their survivorship care.
Purpose
The purpose of this chapter is to provide details about the project’s methods. This
includes the project purpose, project design, institutional review board (IRB) approval and
process, target population, instrument, risks and benefits, instrument, data collection and
management, timeline, and project analysis. The project’s goal was to evaluate cancer nurse
providers’ implementation of the 2018 Commission on Cancer SCP requirement. This
requirement is Standard 3.3, which requires that 50% of eligible cancer survivors receive an
SCP. Eligible patients are defined as in stage I, II, or III but do not include stage 0 or IV (COC,
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2016). This standard is a requirement of cancer center or program accreditation through 2020
(COC, 2016).
Project Design
This was a quantitative nonexperimental study design with descriptive statistics for data
analysis, which was the most appropriate method for this study. The rationale for using
descriptive statistics for this project was that it is utilized to describe quantitative data within
tables, graphs, charts, and percentages (Credo Reference, 2001). Descriptive statistics give an
overall summary of the survey data from this project.
Before the project commencement, IRB approval of an exempt application with a consent
waiver at ACU was obtained. A consent waiver was requested as no identifiable information was
being collected. Participants were selected via an oncology nurse society organization (Oncology
Nurse Society) LISTSERV. The nurse organization emailed its members an email invite; the
consent form, which did not require signatures (e.g., a consent waiver); and the link to the online
survey (Appendix A). The online survey provider was SurveyMonkey.
The project researcher did not have any access to participants’ personal information. All
study activities were conducted through the Oncology Nurse Society (ONS). Those who chose to
participate had a 20-item survey to complete. There was an expectation of a 10%–15% response
rate from ONS members receiving the email invite. Each participant who chose to participate
completed the survey. The study duration for data collection or survey responses was 1 month.
The 1-month time frame allowed ONS to send email reminders to the participants at the 2-week
time frame, which allowed a total of 4 weeks to participate. All deidentified data were exported
from the online survey tool (i.e., SurveyMonkey) and imported into a research database for
statistical analysis.
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Institutional Review Board Approval and Process
IRB review and approval at ACU were required for the project proposal, consent, data
tool, and any other study materials before the execution of this study. A schedule of events was
followed to ensure the project timeline remained on track. A power analysis was conducted,
resulting in a minimum sample size of 128 study participants to reach statistical significance.
ONS filtered its members by selecting participants who are nurses practicing within an oncology
setting. The participants received a consent form that described the study, an email invitation,
and the link to the project survey. There was no compensation for participating in this project
survey.
Target Population
This project involved English-speaking oncology nurse providers who were members of
an oncology nurse organization. The oncology nurse organization was the Oncology Nurse
Society, which had approximately 35,000 oncology nurse members, including registered nurses
and advanced nurse practitioners. This project was only focused on nurses’ (i.e., registered
nurses, advanced practicing nurses, etc.) insights and responses to the study survey. Also, ONS
waived its fee for the number of emails they would send.
Risks and Benefits
There were minimal risks to the study participants for being part of this study as no
identifiable or personal health information was collected. There may not be any direct benefits to
the study participants who participated. However, any benefits may include information learned
during the research and may be applied to the future of improving the utilization and
implementation of the survivorship care plan and patients’ outcomes.
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Instrument Tool
The tool used was the survivorship care plan utilization questionnaire (Appendix A).
Permission to use this tool was obtained from the author of the survey, Dr. Sarah Birken of the
University of North Carolina, Chapel Hill. There was no fee to use or duplicate this tool. The
author requested that the tool be cited. This SCP utilization questionnaire is an 18-item tool that
measures the percentage of development and implementation of SCPs as well as other items of
interest (Birken et al., 2019). The tool included two additional questions specific to this study;
therefore, the tool used was a 20-item survey.
This tool was not validated. However, this tool was used on 395 providers in a published
study by Sarah A. Birken. Dr. Birken published her data in “Survivorship Care Plan
Implementation in US Cancer Programs: A National Survey of Cancer Care Providers” in the
Journal of Cancer Education in 2019 (Birken et al., 2019). This tool was in English only. A copy
of the 20-item survey is also included in Appendix A.
Data Collection and Management
This project included an online survey via SurveyMonkey that was administered to
cancer nurse providers who were members of ONS. The nurses were recruited and emailed via a
LISTSERV by an ONS administrator. ONS emailed the nurses an invite, a consent form with the
project information, and a link to the online survey. The survey included 20 items to be
completed. It should have only taken 5 to 6 minutes for a participant to complete. It was
expected that only 10%–15% of the members who received the email invite would respond to the
survey. ONS sent an email reminder to the participants to remind them to complete the survey, if
they had not done so, in 2 weeks. The deidentified data from SurveyMonkey were exported in
Excel format and then uploaded into a statistical analysis program.
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The deidentified data collected during this project were stored in a secure university drive
under the project researcher’s name. Data are owned by the university in case access is needed at
a future date. This storage system is provided by the online graduate school for doctoral student
research data and supported by the university’s IT department for security purposes and kept for
the minimum required time according to IRB guidelines.
Timeline
The timeline of any clinical study is dependent on the IRB’s review and approval and
collaborating organizations. The projected timeline for this project included IRB submission in
July 2020, with an expectation that IRB approval would be received by July 2020. Once IRB
approval was received, a final packet was sent to the Oncology Nurse Society (ONS) for its
review and approval. Upon the ONS approval, an email blast was sent from ONS to the nurse
members. It was expected that all survey completion would be done by August 2020. Data
analysis was completed by December 2020. The final study closeout was expected to be by July
2021.
Study Analysis Plan
Survey responses were exported from the online survey into SPSS format. Descriptive
statistics, including percentages, medians, and ranges, were used to analyze the data. The data
were further analyzed to provide insights into the cancer nurse providers’ implementation of
survivorship care plans in their clinical practice.
Chapter Summary
It was essential to gain an understanding of the percentage of use of the SCP in the
survivorship care phase of the cancer journey and the nurses’ views of SCP utilization. In order
to recommend a practice change with the current survivorship care programs, the outcomes from
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this project provided further insights into the importance of patients transitioning from active
treatment to long-term survivorship care. The study followed all regulatory requirements and
received IRB approval for all study items used before the execution of this project.
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Chapter 4: Results
Survivorship Care Plan Survey Data Analysis
A total of 406 study participants took part in the SCP survey. The survey consisted of 20
items with mostly defined variable responses. Some survey items allowed for multiple variable
responses to a question. Inadvertently, one survey item allowed for a free-text response. If the
study participant selected no on the first survey item, the survey ended for these participants as
the remaining survey was not relevant to these participants.
Out of the 406 study participants, 59 (14.53%) answered no, and 347 (85.47%) of them
answered yes to the first question, which asked if SCPs are used in their cancer center program.
This question gave insight as to what percentage, if more than half, of cancer center programs
utilize survivorship care plans. To answer this question, a binomial test of proportions was run.
Based on a p value of less than .0001, there is strong evidence to support the claim that over half
of the cancer programs use SCPs. The estimated proportion of cancer programs that used SCPs
was 85.47%. A 95% confidence interval for the true proportion of all such programs that used
SCPs was (82.04%, 88.90%).
All study participants were registered nurses who work within the oncology setting. To
better understand their role, the survey asked what their current position was in the cancer
program. For this question, because the subjects can choose more than one answer, it is
important to keep in mind that the sum of the frequencies of the response variable categories
could be more than 100%. The results were as follows: 39.41% of the subjects were registered
nurses, 24.14% were non-oncology nurse practitioners, 0.99% were oncology nurse practitioners,
16.26% were nurse navigators, 4.19% were oncology nurse educators, and 21.40% belonged to
other categories. To help show the positions of these nurses, Table 1 summarizes the findings.
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The first column contains the response variable, the second column contains the number of
subjects who selected that response, and the last column has the percentage of subjects who
selected that response.
Table 1
Survey Item: What Is Your Current Position in the Cancer Program
Variables

n

%

160

39.41

98

24.14

4

0.99

Oncology nurse navigator

66

16.26

Oncology nurse educator

17

4.19

Other

86

21.40

Registered nurse (RN)
Non-oncology nurse practitioner (NP)
Oncology nurse practitioner (NP)

To better understand the study participants’ nursing experience level, the survey asked
how many total years of experience. The results were as follows: 0.94% of the subjects had less
than 2 years of experience, 3.20% had between 3 and 5 years of experience, 10.59% had between
6 and 10 years of experience, 10.84% had between 11 and 15 years of experience, and 74.63%
had more than 15 years of experience. To understand the study participants’ role in caring for
cancer survivors, the survey asked what their role in the care of cancer patients was. Some
subjects selected more than one response, which is why the sum of the total percentages was
more than 100%. The results were as follows: 16.01% had administration roles, 49.26% had
clinical outside survivorship care roles, and 42.35% had other roles. Most of the subjects had
clinical outside survivorship care roles.
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The survey asked if the study participants thought that an SCP was beneficial to cancer
survivors, and the responses produced a significant p value. Tables 2 and 3 summarize the
findings. For Table 2, the first column contains the response variable, the second column
contains the number of subjects who selected that response, and the last column has the
percentage of subjects who selected that response. .The findings were as follows: 61.82%
strongly agreed that SCP was beneficial to cancer survivors, 26.85% agreed, 8.87% were neutral,
2.46% disagreed, and none of them strongly disagreed. Table 3 summarizes the t test performed
to find out if the response variable was significant or not
There was great interest in determining whether the mean response to this question was
significantly greater than 3, which would indicate that, on average, the health care workers
agreed that SCPs were beneficial to cancer survivors. A one-sample t test was run to answer this
research question. The t test was performed at an α = 0.05 significance level. Based on a p value
of less than .001, I concluded that there was strong evidence to suggest the mean level of
agreement was significantly greater than 3, which corresponds to neutral. A 95% confidence
interval for the true mean level of agreement was (4.41, 4.55).
Table 2
Survey Item: Do You Think an SCP Is Beneficial to Cancer Survivors?
Variable

n

%

Strongly agree

251

61.82

Agree

109

26.85

Neutral

36

8.87

Disagree

10

2.46

0

0

Strongly disagree
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Table 3
The t Test Procedure
N

M

SD

SE

Minimum

Maximum

406

4.4803

0.7590

0.0377

2.0000

5.0000

Note. Variable: Q5_num (Q5_num). df = 405; t value = 118.93; p value < .0001.
The survey asked about SCP utilization and which variable option best describes SCP
uses in their cancer program. The options included SCPs are used regularly, SCPs are sometimes
used, SCPs were previously used but we no longer use them, and never used them. The results
were as follows: 50.99% said SCPs were used regularly, 36.21% said SCPs were sometimes
used, 2.46% said SCPs were previously used but no longer used, and 10.34% said they were
never used. The survey asked who at their institution completed the SCP. Some subjects selected
more than one response, which is why the sum of the total percentages is more than 100%. The
results were as follows: 27.34% said registered nurses completed the SCP, 2.71% said nononcology nurse practitioners, 44.33% said oncology nurse practitioners, 30.30% said oncology
nurse navigators, 1.97% said oncology nurse educators, and 20.17% said others complete the
SCP. Table 4 summarizes the findings.
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Table 4
Survey Item: Who at Your Institution Completes the SCP?
Variables
Registered nurse (RN)

n

%

111

27.34

11

2.71

Oncology nurse practitioner (NP)

180

44.33

Oncology nurse navigator

123

30.30

8

1.97

81

20.17

Non-oncology nurse Practitioner (NP)

Oncology nurse educator
Other

The survey asked approximately when SCP use began in their cancer program. The
findings were as follows: 37.93% said the SCP use began between 2015 and 2016, 24.88% said
it began between 2017 and 2018, 5.17% said it began between 2019 and 2020, and 32.51% did
not know when it began. Then the survey asked approximately what percentage of providers in
their cancer program had used SCPs. The findings were as follows: 16.26% of the subjects said
less than 25% had used the SCPs, 14.78% said between 26% and 50% had used the SCPs,
12.07% said between 51% and 75% had used the SCPs, 20.20% said between 76% and 100%
had used the SCPs, and 36.70% did not know.
The survey asked for approximately what percentage of all survivors in the cancer center
were SCPs developed. Table 5 summarizes the findings. The first column contains the response
variable, the second column contains the number of subjects who selected that response, and the
last column has the percentage of subjects who selected that response. The findings were as
follows: 14.78% said SCPs were developed for less than 25%, 15.02% said between 26% and
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50%, 18.47% said between 51% and 75%, 12.81% said between 76% and 100%, and 38.92% did
not know.
Table 5
Survey Item: Percentage of All Survivors in the Cancer Center for Whom SCPs Are Developed
Variables

n

%

0%–25%

60

14.78

26%–50%

61

15.02

51%–75%

75

18.47

76%–100%

52

12.81

Do not know

158

38.92

The survey asked approximately what percentage of SCPs were delivered to survivors.
Table 6 summarizes the findings. The first column contains the response variable, the second
column contains the number of subjects who selected that response, and the last column has the
percentage of subjects who selected that response. The results were as follows: 13.05% said less
than 25% were delivered to survivors, 14.78% said between 26% and 50% were delivered,
20.20% said between 51% and 75% were delivered, 15.27% said between 76% and 100% were
delivered, and 36.70% did not know.
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Table 6
Survey Item: Approximately What Percentage of SCPs Are Delivered to Survivors
Variables

n

%

0%–25%

53

13.05

26%–50%

60

14.78

51%–75%

82

20.20

76%–100%

62

15.27

Do not know

149

36.70

The percentage of SCPs that are delivered to survivors’ primary care providers was asked
of the participants. Some subjects selected more than one response, which is why the sum of the
total percentage is more than 100%. The results were as follows: 18.23% said less than 25%
were delivered to survivors’ primary care providers, 8.37% said between 26% and 50% were
delivered, 7.64% said between 51% and 75% were delivered, 16.50% said between 76% and
100% were delivered, and 49.26% did not know.
The survey asked participants, for survivors, for which tumor groups had SCPs been used
or would SCPs be used. The results were as follows: 80.30% belonged to the breast tumor group,
57.14% belonged to the colorectal group, 31.03% belonged to the testicular group, 44.83%
belonged to the prostate group, and 45.03% belonged to other groups. The survey asked what
kinds of SCP templates had been or would be used. Some subjects selected more than one
response, which is why the sum of the total percentage is more than 100%. The results were as
follows: 6.65% used the Livestrong care plan, 35.71% used the ASCO survivorship care plan,
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13.05% used the Journey Forward, 36.45% used a plan developed in their cancer program,
39.16% planned this as part of an electronic health record, and 14.64% used other templates.
The survey asked why did or would the cancer program begin using SCPs. Some subjects
selected more than one response, which is why the sum of the total percentage is more than
100%. The results were as follows: 58.37% said the desire to comply with the American College
of Surgeons (ACOS) Commission on Cancer (CoC) cancer program 2012 standards, 16.01% said
the desire to comply with the Association of Community Cancer program (ACCC) 2009
guidelines, 9.85% said the desire to comply with National Coalition for Cancer Survivorship
(NCCS) or Lance Armstrong Foundation recommendations, 38.92% said the desire to comply
with American Society for Clinical Oncology (ASCO) practice guidelines, 43.10% said the
desire to comply with National Comprehensive Cancer Network (NCCN) guidelines, 22.22%
said the desire to comply with National Cancer Institute (NCI) Community Cancer Centers
Program (NCCCP) guidelines, 14.04% said the IOM’s From Cancer Patient to Cancer Survivor
raised awareness, 3.69% said because the grant-funded SCP use project raised awareness, 9.11%
said a colleague had raised awareness, 2.96% said competing with a cancer program that uses
SCPs, 16.50% said it was a commonly accepted practice, 16.80% said the belief that it might
improve the quality of care, 2.96% said survivors had requested SCPs, and 10.95% said other
reasons.
The survey asked the participants’ opinions of the barriers to SCP used in their cancer
program. Some subjects selected more than one response, which is why the sum of the total
percentage is more than 100%. The results were as follows: 32.35% said the perception was that
SCPs were not useful, 17.98% said the perception was that SCPs were difficult to use, 27.59%
said influential people (e.g., physician champions, managers) had not advocated for SCPs to be
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used, 16.75% said influential people (e.g., physician champions, managers) advocating for SCPs
to be used did not motivate providers to use SCPs, 63.05% said there were not enough resources
(e.g., time, staff, training, money) to use SCPs, 5.67% said there were not enough opportunities
to use SCPs, 11.08% said the providers did not feel confident in using SCPs, and 16.48% said
other barriers.
Table 7
Survey Item: What Barriers to SCP Use in Your Cancer Center
Variables
Q16_SCP_Not_usefu

n

%
131

32.35

73

17.98

112

27.59

68

16.75

Q16_not_enough_resour

256

63.05

Q16_not_enough_opport

23

5.67

Q16_prov_not_confid

45

11.08

Q16_other

66

16.48

Q16_SCP_diffi
Q16_infl_no_advo
Q16_infl_no_motivat

The survey asked the participants approximately how many new cancer patients were
seen in their cancer program per year. There were many different responses to this question
because the subjects could input their responses. I tried my best to combine similar answers. For
example, for people who did not know, some of the input words included IDK (i.e., idk), do not
know, I do not know, I do not know, not known, unsure, not certain, uncertain, unknown, no idea,
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have no idea, and similar. For this specific example, I combined all these responses into one
variable called “Unknown.” This survey item’s data point was inconclusive.
The survey asked the participants to indicate their cancer program type. Some subjects
selected more than one response, which is why the sum of the total percentages is more than
100%. The findings were as follows: 30.79% selected the NCI-designated or academic hospital
type, 37.93% the community hospital cancer center, 31.77% the hospital associated cancer
program, 1.48% the pediatric hospital cancer center, and 8.87% did not know. The survey asked
the participants which professional society or societies their cancer program was a member of.
Some subjects selected more than one response, which is why the sum of the total percentages is
more than 100%. The results were as follows: 24.63% were members of the Association of
Community Cancer Centers (ACCC), 5.74% are members of the American College of Surgeons
(ACoS) Commission on Cancer (COC), 3.69% were members of the National Coalition for
Cancer Survivorship (NCCS), Lance Armstrong Foundation, 42.12% were members of the
American Society for Clinical Oncology (ASCO) Quality Oncology Practice Initiative (QOPI),
41.13% were members the National Comprehensive Cancer Network (NCCN), 15.27% were
members of the NCI Community Cancer Centers Program (NCCCP), and 24.28% were members
of other societies. The last survey item asked the participants to provide the region of the United
States where their cancer program or center was located. The results were as follows: 26.85%
were in the Midwest region, 24.88% in the Northwest region, 25.86% in the South region, and
22.41% in the West region.
Chapter Summary
The key findings of this survey included the following:
•

85.47% of participants responded yes regarding SCPs being utilized in their cancer
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program. This revealed a p value of less than .0001.
•

A significant p value of less than .0001 was revealed related to the participants’
response that SCPs were beneficial to cancer survivors.

•

62.81% began the use of SCPs from years 2015 through 2018 (37.93% began 2015–
16 and 24.88% began in 2017–18). However, 5.17% began in 2019–20 and 32.51%
were unaware of when SCP utilization began.

•

38.92% of participants were unaware of for what percentage of all survivors in their
cancer center SCPs were developed, 36.70% of participants were unaware of what
percentage of SCPs were delivered to survivors, and 49.26% of participants were
unaware of the percentages of SCPs delivered to survivors’ primary care provides.

•

63.05% of participants responded that not enough resources were available, 32.35%
of participants responded that SCPs were not useful, and 27.59% of participants
responded that there were no influential advocates (i.e., physicians, champions,
managers) as barriers to SCP use.
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Chapter 5: Discussion, Conclusions, and Recommendations
The enthusiasm for this project regarding cancer survivors’ survivorship care grew from
observing cancer survivors who went through the cancer journey and had reached the point in
their cancer journey of end of treatment. Once cancer treatment is completed and no further risks
persist requiring follow-up with an oncologist, the survivor is released back to the community.
There seems to be no clear understanding of who is responsible, including the patient, and what
ongoing follow-up involves. Cancer survivors being released back to the community or their
primary care physician is not as seamless as one may expect. Primary care physicians’ focus is
usually not cancer survivorship care. Therefore, the purpose of this study was to understand
whether cancer nurse providers were implementing the 2018 Commission on Cancer (COC)
survivorship care plan requirement within the survivorship care phase of the cancer survivor’s
journey. In developing and receiving a survivorship care plan, cancer survivors may have a better
transition and understanding of their cancer, treatment, and ongoing follow-up.
For this study, the 2018 COC Standard 3.3, Survivorship Care Plan, required greater than
or equal to 75% of eligible cancer survivors to receive a survivorship care plan. Eligible cancer
survivors include patients who are staged I–III and have completed treatment. There was no
hard-and-fast rule that staged IV cancer survivors could not receive a survivorship care plan. At
present, the 2018 COC Standard 3.3 has been revised to Standard 4.8, Survivorship Program, and
this standard only requires survivorship programs to offer cancer survivors three services within
a list of services to be compliant. This revision only entails survivorship care plans as an optional
service to be offered and is encouraged but not required. Consequently, a survivorship care plan
is no longer a hard requirement of this standard. This revised requirement only encourages
providers to provide a survivorship care plan to cancer survivors as one of the services offered
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within the institution’s survivorship program. Unfortunately, the hard requirement of providing
this useful tool, a survivorship care plan, is no longer a condition of the COC standard. However,
the institution could opt to fulfill one of its three services requirements by providing survivors a
survivorship care plan at their cancer survivorship program to fulfill the current standard’s
requirement.
IRB review and approval were obtained before the commencement of this study. The data
for this study were collected by using an online 20-item survivorship care plan survey that was
developed in SurveyMonkey. In collaboration with the Oncology Nursing Society (ONS), the
survey was emailed to members who were registered nurses within the oncology field. ONS
handled all communication with the survey participants. The survey participants had 4 weeks to
complete the survey. The survey went out at Week 1 and then was resent 2 weeks later. No
participant names or contact information was shared with me.
The data were exported from the online survey tool (i.e., SurveyMonkey), and then 19 of
the 20 questions were analyzed utilizing descriptive statistics. One of the 20 questions, a t test,
was performed. In my analysis, I discovered that even though the COC’s standards had changed
from 2015 to current, more than half of the cancer center programs across the United States
claimed to utilize the survivorship care plan with their cancer survivors. Also, these nurse
participants strongly agreed that survivorship care plans were beneficial for cancer survivors.
Both questions proved to be statistically significant.
Limitations
There were limitations to this study, which included the following: (a) The survey was
not a validated survey (some questions allowed multiple responses and one question allowed free
text), (b) there were no health outcomes data for cancer survivors receiving a survivorship care
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plan, (c) the scope of this study was limited to cancer nurse providers and, thus, not all health
care providers were included, (d) there was no solution for existing barriers to developing and
implementing survivorship care plans, and (e) the COC standards have constantly changed.
These limitations affected the ability to effectively evaluate SCP full utilization practice against
standards as well as understanding its impact on cancer survivors.
Unfortunately, there is no consistency with survivorship care plan development and
implementation. The Commission on Cancer has revised its standards since the beginning of this
project, in which survivorship care plans are only an option for cancer center programs to offer
and not a requirement. The standard has had many changes since its beginnings and so this is
also a confusing factor and may have contributed to less than 75% of eligible cancer patients
receiving survivorship care plans. The utilization of survivorship care plans has seemed to
diminish in recent years, and this may correlate with the published COC standards of offering
survivorship care plans only as an optional service. But the survey did not allow for further
discoveries around the potential decline in usage.
Since the scope of this study was limited to cancer nurse providers, and thus not all health
care providers were included, this may have affected the study results. However, nurses’ voices
were represented well in this survey’s results in that nurses on average agreed that SCPs were
beneficial to cancer survivors.
Interpretation of Findings
There were 406 participants who responded to the survey. Three hundred forty-seven
participants reported that survivorship care plans were utilized in their cancer center program.
The participants behind these data were cancer nurse providers who were registered nurses from
various cancer centers and programs. Most of the nurses who participated in this study had more
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than 15 years of nursing experience. These experienced nurses on average agreed that
survivorship care plans were beneficial for cancer survivors. While these nurses agreed that
survivorship care plans were important, it was reported that many patients or primary care
providers of these patients may not be receiving the survivorship care plan. More than half of the
nurse participants indicated that survivorship care plans were regularly used, and a small
percentage indicated that their center had stopped using or had never used survivorship care
plans. Most individuals who completed the survivorship care plans in cancer center survivorship
programs were cancer nurse providers (i.e., registered nurses, non-oncology nurse practitioners,
oncology nurse practitioners, or oncology nurse navigators). However, 20% reported they were
completed by other individuals. This study demonstrated that there still seems to be a gap and
inconsistencies with survivorship care plan development and implementation.
Among these nurse participants, who represented many cancer programs across the
United States, survivorship care plan development began mostly between 2015 through 2018.
Five percent began utilizing survivorship care plans in 2019 through 2020, and over 30% did not
know when they began utilizing survivorship care plans. The percentage range of providers in
the participants’ cancer programs using survivorship care plans were across the board. Most
participants did not know what percentage of providers utilized survivorship care plans. It
appeared that 66% to 100% was the second-highest percentage range of providers utilizing
survivorship care plans. Most nurse participants indicated they did not know what percentage of
survivorship care plans were developed. Most of the nurse participants indicated they did not
know what percentage of survivors received survivorship care plans. Also, most nurse
participants did not know if the survivorship care plans were delivered to the survivor’s primary
care physician. Survivorship care plans were mostly utilized in breast cancer cases. Remarkably,
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colorectal, prostate, testicular, and other cancer cases also utilized survivorship care plans. More
than 90% of the survivorship care plan templates utilized were ASCOs, customized, and existed
within the institution’s electronic health care record. It is unclear if the survivorship care plan
incorporated within an electronics health care record was customized or used Livestrong’s,
ASCO’s, or Journey Forward’s template. Livestrong and Journey Forward were the least utilized
among the templates noted in the survey.
The same barriers noted within current literature seemed to be some of the same barriers
to survivorship care plan use in cancer survivorship programs. Based on this study, the top three
survivorship care plan barriers noted within this study were not enough resources, viewed as not
useful, and no influential provider advocate. Notably, not having enough resources seemed to be
the biggest barrier in the way of cancer survivors receiving survivorship care plans and, hence,
SCP development and implementation (i.e., SCP full utilization).
The cancer program types represented in the survey results included NCI-designated or
academic hospital, community hospital cancer center, hospital-associated cancer program,
pediatric hospital cancer center, and types unknown. NCI-designated or academic hospital and
community hospital cancer centers were the largest representation. The top three most
represented societies that these cancer center types belonged to were ASCO, NCCN, and
NCCCP. The cancer centers represented in this survey had an even spread across the United
States; the regions included the Midwest, Northeast, South, and West.
Implications of Analysis for Leaders
Cancer survivors should experience the same level of high-quality care they are
accustomed to as they move through the phases of the cancer journey. While this project scope
did not include health outcomes, it did reveal that most nurses surveyed believed that SCPs were
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beneficial to patients. Also, SCPs were being used in some capacity. However, consistent
development and implementation were not currently the practice with many cancer centers and
programs.
Other outcomes of this study revealed that the same barriers of time, no influential
executive sponsor, and negative beliefs existed. To support cancer survivors after active
treatment is to change the current practice of inconsistent survivorship care plan utilization to
consistently utilizing. Also, the survivorship care phase should be a dedicated clinical or, at a
minimum, subspecialty clinic so that long-term survivorship care delivery is the primary focus of
such a clinic.
EBP Findings and Relationships to DNP Essentials I–VIII
The project addressed registered nurses within cancer centers or programs across the
United States. With the scope of this project, the DNP Essentials findings and relationships are
outlined below:
I.

Scientific underpinnings for practice: Nurses’ voices together can support a change in
the practice of cancer survivors consistently receiving an SCP. The transitioning from
active treatment to survivorship care to one’s primary care physician or community
nurse practitioner requires communication and coordination of care. Many cancer
patients may not understand all the treatments, recurrence risks, and potential late
and/or long-term effects associated with their cancer and treatments. The utilization
of an SCP may support the necessary communication and coordination of care and
provide a smoother transition out of the oncology setting and into the community
setting for the survivor. It is important to remember that the cancer survivor will have
spent many months or years focused on conquering and surviving their cancer once
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they reach the point of transition to survivorship care. Consequently, SCPs could help
to fill the gap in communication and coordination of post–cancer treatment care.
Also, the SCP tool can help educate the cancer survivor, help them be more engaged
about their previous treatments, and empower them to be more engaged with their
primary care physician or community nurse practitioner in their survivorship care.
Therefore, SCPs must not be pushed aside as cancer survivors report that they
experience significant lasting symptoms and functional constraints once they have
completed active cancer treatments and moved into the survivorship phase (Wu &
Harden, 2015). The conversation about SCP utilization has been occurring for more
than 15 years, in which the IOM recommended that cancer survivors who had
completed their active treatment should be provided a survivorship care plan. The
SCP should include the survivor’s cancer, stage, treatments, and possible side effects;
posttreatment follow-up requirements; mental problems; and any recommendations
for legal protection since some cancer survivors are left with disabilities related to
their cancer and treatments (National Research Council, 2006). This recommended
practice must continue so that patients in the survivorship phase continue to receive
high-quality follow-up cancer care, potentially minimize negative outcomes, and get
the patients engaged.
II.

Organizational and systems leadership: Most of the nurses who participated and
responded to the survey acknowledged that SCPs are beneficial to cancer survivors.
Nurses are usually more intimately involved with patients at the bedside, clinic, and
hospitals, and thus their voices and even intuition should not be ignored. Nurses play
an important role in advocating for patients, and their demonstrated support of
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consistent utilization of SCPs for cancer survivors who are entering the survivorship
phase of their care in this study is a significant finding. Therefore, a recommendation
to health care organizations is to incorporate consistent full utilization (i.e.,
development and implementation) of SCPs as a tool to support smooth transitions,
communication, coordination of care, and engaging patients to own their health care.
Another recommendation is to figure out new clinical models that would support the
primary focus on cancer survivors entering and those who are already within the
survivorship phase. Other models may include a nurse-led survivorship clinics
(virtual or face-to-face), incorporating a dedicated survivorship care subspecialty
clinic, and/or a standalone specialty survivorship primary care clinic.
III.

Clinical scholarship and analytical methods for evidence-based practice: This project
surveyed oncology nurses about their opinions of cancer survivors receiving an SCP.
The survey results demonstrated that most nurses believed that cancer survivors
receiving an SCP is a beneficial practice. This project also showed that SCPs were
not consistently developed or implemented. While the practice of completing the SCP
typically resides with the oncology physician, nurses (i.e., advance practice registered
nurses) could provide this service in a dedicated specialty primary care survivorship
clinic or it could become its own subspecialty. Nurses work closely with patients
throughout their health care journey and understand the complexity and fragmentation
of the health care system and the importance of communication and care coordination
for setting patients up for the best outcomes. Unfortunately, there are limited
resources for SCP full utilization or service and influential advocates in existing
clinics and programs at many cancer centers. However, it is logical as to why it is
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difficult to have survivorship care as another primary focus of an oncology clinic and
hospital, as diagnosing and treatments are their focus. Another difficulty includes an
era when more and more patients are being diagnosed with cancer and undergoing
various active treatments (i.e., surgeries, chemotherapy, and radiation). A dedicated
clinic or subspecialty clinic where the primary focus is on the delivery of survivorship
care and SCPs full utilization would allow for more coordinated care,
communication, and opportunities to engage cancer survivors during survivorship.
IV.

Information systems and patient care technology for the improvement and
transformation of health care: Downloadable templates have been developed for the
use of developing and implementing SCPs. Some templates are information systems
and, in some cases, maybe operationalized within an electronic health care record
system. OncoLink provides a web-based SCP template for health care providers and
patients to complete (OncoLink, 2021). This list is not all-inclusive of SCP templates
but demonstrates that there are existing SCP templates for utilization. These templates
and utilization offer patients an opportunity to better understand their cancer and their
treatments, increase communication between their providers, potentially improve care
coordination, and become engaged. In turn, cancer survivors may have their unmet
needs addressed, reduce fear of recurrence and late- and long-term effects, and
possibly improve their quality of life and health outcomes.

V.

Health care policy for advocacy in health care: This study showed that the oncology
nurses who participated worked within cancer centers with survivorship programs
offering SCPs. Most of these nurse respondents had more than 15 years of experience
as a nurse, and the majority of the other nurse respondents had between 6 and 15
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years of nursing experience. This means that these nurses were well versed in the care
of patients and the importance of supporting efforts towards survivors’ positive
outcomes. Their recommendation and the statistical significance of SCPs being
beneficial for cancer survivors is a solid recommendation for SCP utilization in
survivorship care. To properly offer services to develop and implement a survivorship
care plan, a dedicated clinic or subspeciality with survivorship care as its primary
focus is needed.
VI.

Interprofessional collaboration for improving patient and population health outcomes:
Nurses are well positioned to make this practice change of consistent full utilization
of SCPs. Also, a dedicated survivorship care specialty clinic is needed to support the
primary focus of long-term survivorship care delivery and not the current
survivorship care program. This practice change may increase communication and
care coordination, meet unmet needs, and possibly improve the health outcomes of
cancer survivors who enter and remain in the survivorship care phase of their cancer
journey. For this practice change to work, financial models would need to align
accordingly.

VII.

Clinical prevention and population health for improving the nation’s health: The
survey utilized for this project demonstrated that most oncology nurses believed that
SCPs are beneficial to cancer survivors’ ongoing care. These oncology nurses’ voices
support the consistent utilization of SCPs for cancer survivors moving into the
survivorship phase. The importance of care coordination and communication among
providers may help to improve this patient population’s health outcomes. The
statistical significance of these nurses’ response that SCP utilization is beneficial to
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cancer survivors should not be ignored.
VIII.

Advance nursing practice: Nurses are well positioned to make this practice change
(consistent full utilization of SCPs and move from a program to a dedicated specialty
clinic) to potentially improve the care coordination and health outcomes of cancer
survivor patients who enter the survivorship care phase of their cancer journey.
Nurses are trained to work collaboratively with other disciplines to effectively care
for patients and for the best outcomes. Nurses are well positioned to change practice
from inconsistent to consistent SCP full utilization and to move this practice from a
program to a dedicated specialty survivorship care clinic (virtual or face-to-face).
Many cancer survivors may be within unmet needs areas, and thus the SCP full
utilization practice would also potentially support these patients.

Recommendations for Future Research
Continued research on the full utilization of SCPs and the associated benefits must
continue. Further research must be done to evaluate the SCP’s direct impact on cancer survivors’
health outcomes, physical and psychosocial. A study should be conducted to evaluate the
outcomes or effects of consistently developing and implementing SCPs as one of the three
services offered to cancer survivors in a cancer survivorship program following the COC’s
standards. In doing so, perhaps an understanding of whether there are positive health outcomes
associated with SCP implementation or usage could be revealed along with other insights. Any
positive health outcomes revealed may have an encouraging effect on conquering current barriers
and potentially increase influential advocates for SCP usage. Until then, the true impact of SCPs
will not be fully understood. Also, the execution of Lewin’s change model from inconsistently
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developing and implementing SCPs to consistently developing and implementing SCPs will not
be realized.
Other research opportunities would include conducting a randomized trial with larger
sample sizes to evaluate the utilization of SCPs versus nonutilization and the direct impact on
health-related outcomes. Also, research needs to be conducted on the feasibility and
sustainability of a dedicated survivorship specialty clinic (virtual or face-to-face) for cancer
survivors.
Chapter Summary
This study demonstrated statistical significance that over half of the U.S. cancer programs
use SCPs in some fashion. The biggest motivation behind the utilization of survivorship care
plans is related to compliance to requirements set by organizations such as Commission on
Cancer, American Society for Clinical Oncology, National Comprehensive Cancer Network, and
National Cancer Institute. Nevertheless, the statistical significance of cancer nurse providers on
average agrees that survivorship care plans are beneficial for cancer survivors. This feedback
resonates with the ongoing desire for SCP usage with cancer survivors in the survivorship care
phase. These nurses’ voices should not be overlooked as nurses are intimately involved with the
care of patients and, in this environment, cancer survivors. This may be an example of where
experienced nurses’ intuition about SCP’s benefit to cancer survivors and its associated positive
health outcomes cannot be scientifically captured. The findings of this study and prior literature
support an opportunity for developing a specialty clinic dedicated to cancers survivors who enter
the long-term survivorship phase to ensure that survivors’ needs are a primary focus.
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Appendix A: Survivorship Care Plan Utilization Survey
1. Are survivorship care plans (SCPs) used in your cancer program? (Note: An SCP is a
written document that often, but not always, includes the following information regarding
care after cancer treatment is complete: treatment summary; surveillance plan; preventive
care; and symptoms to report). Please check one.
Yes -> Please proceed to question 2.
No -> Please do not proceed. (Thank you for your time and consideration to complete this
survey)
2. What is your current position in the cancer program? Please check one.
Registered Nurse (RN)
Oncology Nurse Practitioner (NP)
Non-Oncology Nurse Practitioner (NP)
Oncology Nurse Navigator
Oncology Nurse Educator 1
Other (please specify)
3. Total years of experience.
Less than or equal to 2
3-5
6-10
11-15
Greater than 15
4. What is your role in the care of cancer patients? Check all that apply.
Administration Role (e.g., nurse manager, nurse supervisor)
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Clinical Outside Survivorship Care (e.g., staff nurse in clinic/hospital, research nurse,
scheduler)
Other (please specify)
5. Do you think and SCP is beneficial to cancer survivors? Please check one.
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
6. Which of the following options best describes SCP use in your cancer program? Please
check one.
SCPs are used regularly.
SCPs are sometimes used.
SCPs were previously used, but we no longer use them.
Never Used

Please proceed to Question 16.

7. Who at your institution completes the SCP?
Registered Nurse (RN)
Oncology Nurse Practitioner (NP)
Non-Oncology Nurse Practitioner (NP
Oncology Nurse Navigator
Oncology Nurse Educator
Other (please specify)
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8. Approximately when did SCP use begin in your cancer program? Please check an
appropriate start date or check "Do not Know.”
2015-2016
2017-2018
2019-2020
Do not Know
9. Approximately what percentage of providers in your cancer program has used SCPs?
Please check one percentage or "Do not Know.”
0-25%
26-50%
51-75%
76-100%
Do not Know
10. Approximately what percentage of all survivors in your cancer center are SCPs
developed? Please check one percentage or "Do not Know.”
0-25%
26-50%
51-75%
76-100%
Do not Know
11. Approximately what percentage of SCPs are delivered to survivors? Please check one
percentage or "Do not Know."
0-25%
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26-50%
51-75%
76-100%
Do not Know
12. Approximately what percentage of SCPs are delivered to survivors’ primary care
providers? Please check one percentage or "Do not Know."
0-25%
26-50%
51-75%
76-100%
Do not Know
13. For survivors, in which tumor groups have SCPs been/will SCPs be used? Please check
all that apply.
Breast
Colorectal
Testicular
Prostate
Other (please specify)
14. What kinds of SCP templates have been/will be used? Please check all that apply.
LIVESTRONG Care Plan
American Society for Clinical Oncology (ASCO) Survivorship Care Plan
Journey Forward
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A plan developed in your cancer program (If based on template listed above, please also
check that option.)
Plan this is part of an electronic health record (If based on template above, please also
check that option.)
Other (please specify)
15. Why did/will your cancer program begin using SCPs? Please check all that apply.
Desire to comply with the American College of Surgeons (ACOS) Commission on
Cancer (COC) cancer program 2012 standards
Desire to comply with the Association of Community Cancer program (ACCC) 2009
guidelines
Desire to comply with National Coalition for Cancer Survivorship (NCCS)/Lance
Armstrong Foundation recommendations
Desire to comply with American Society for Clinical Oncology (ASCO) practice
guidelines
Desire to comply with National Comprehensive Cancer Network (NCCN) guidelines
Desire to comply with National Cancer Institute (NCI) Community Cancer Centers
Program (NCCCP) guidelines
Institute of Medicine’s (IOM) From Cancer Patient to Cancer Survivor raised awareness
Grant-funded SCP use project raised awareness
A colleague (s) raised awareness
Competing for cancer program that uses SCPs raised awareness
It’s a commonly accepted practice
A belief that it may improve the quality of care
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Survivors requested SCPs
Other (please specify)
16. In your opinion, what are barriers to SCP use in your cancer program? Please check all
that apply.
The perception is that SCPs are not useful.
The perception is that SCPs are difficult to use.
Influential people (e.g., physician champions, managers) have not advocated for SCPs to
be used.
Influential people (e.g., physician champions, managers) advocating for SCPs to be used
does not motivate providers to use SCPs.
There are not enough resources (e.g., time, staff, training, money) to use SCPs.
There are not enough opportunities to use SCPs.
Providers do not feel confident in using SCPs.
Other (please specify)
17. Approximately how many new cancer patients are seen in your cancer program per year?
Your best guess is fine.
18. Please indicate your cancer program type. Please check all that apply.
NCI-Designated/Academic Hospital
Community Hospital Cancer Center
Hospital Associated Cancer Program
Pediatric Hospital Cancer Center
Do not Know
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19. Which professional society/societies is your cancer program a member? Please check all
that apply.
Association of Community Cancer Centers (ACCC)
American College of Surgeons (ACOS) Commission on Cancer (COC)
National Coalition for Cancer Survivorship (NCCS)/Lance Armstrong Foundation
American Society for Clinical Oncology (ASCO) Quality Oncology Practice Initiative
(QOPI)
National Comprehensive Cancer Network (NCCN)
NCI Community Cancer Centers Program (NCCCP)
Do not Know
20. Please enter the region of the U.S. your cancer program/center is located?
Northeast
Midwest
South
West
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Appendix D: Project Consent

ACU IRB # 20-112

Date of Approval 9/1/2020
Informed Consent Form

Introduction: An Evaluation of Cancer Nurse Providers’ Implementation of the 2018
Commission on Cancer Survivorship Care Plan Requirement
Sponsor:

Abilene Christine University

Investigator(s):

Angelia Drake, RN, MSN (Doctor of Nursing Practice Candidate), Lead
Investigator
Linda Gibson, DNP
Abilene Christine University (ACU)
16633 Dallas Parkway, Suite 800
Dallas, Texas

______________________________________________________________________________
You may be able to take part in a research study. This form provides important information
about the study, including the risks and benefits as a potential to participate. Please read this
form carefully. You may also wish to discuss your participation with other people, such as a
family member. Your participation in this study is completely voluntary and you can withdraw at
any time. You are free to skip any question you choose.
PURPOSE AND DESCRIPTION:
You were selected for this study because you are a cancer nurse provider. The purpose of this
research study is to understand the percentage of utilization and implementation of survivorship
care plans (SCPs) in your cancer center/clinic/program based on the Commission on Cancer’s
2018 requirement. If you agree to take part in this research study, you will proceed with
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completing an on-line survey. It should only take you five to seven minutes to complete this online survey.
RISKS & BENEFITS:
•

The primary risk with this study is breach of confidentiality. However, we have taken
steps to minimize this risk. No personal identifiable information is being shared or
collected.

•

You may not receive any benefit from this study other than providing your responses may
benefit survivors and society. The researchers cannot guarantee that you will experience
any personal benefits from participating in this study.

PRIVACY & CONFIDENTIALITY:
As stated above, the primary risk with this study is breach of confidentiality. However, we have
taken steps to minimize this risk. We will not be collecting any personal identification
information during the survey. However, Survey Monkey may collect information from your
computer. You may read their privacy statements her:
http://www.surveymonkey.com/mp/policy/privacy-policy/.
COMPENSATION FOR INJURY:
The researchers and ACU do not have any plan to pay for any injuries or problems you may
experience by participating in this research.
CONTACTS:
If you have any questions about this research, you may contact the lead researcher, Angelia
Drake, RN, MSN and she may be contacted xxx.xxx.xxxx, or xxxxxx@acu.edu. If you are
unable to reach the lead researcher or wish to speak to someone other than the lead researcher,
you may contact Linda Gibson, DNP, and she may be contacted at xxxxxx@acu.edu.
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If you have concerns about this study, believe you may have been injured because of this study,
or have general questions about your rights as a research participant, you may contact ACU’s
Chair of the Institutional Review Board and Executive Director of Research, Megan Roth, Ph.D.
Dr. Roth may be reached at xxx.xxx.xxxx or xxxxxxx@acu.edu, 320 Hardin Administration
Bldg., ACU Box 29103, Abilene, TX 7969.
CONSENT SECTION:
If you voluntarily agree to participate in this study, then you are consenting that you have read all
the information provided and are satisfied. This also means you will take part in this study and
complete the on-line survey titled Survivorship Care Plan Utilization Survey. Your completed
survey is participating in this study.
Please do not write your name on the survey (e.g., in any free text areas). If you wish to have a
copy of this consent form, you may print it now. You do not waive any legal rights by consenting
to this study.
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